Page last updated: 2024-08-16

temozolomide and navitoclax

temozolomide has been researched along with navitoclax in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
deCarvalho, AC; Mikkelsen, T; Quartararo, CE; Reznik, E; Stockwell, BR	1
Bougras-Cartron, G; Briand, J; Campone, M; Cartron, PF; Frenel, JS; Garnier, D; Guyon, N; Heymann, D; Nadaradjane, A; Raimbourg, J; Vallette, FM	1

Other Studies

2 other study(ies) available for temozolomide and navitoclax

Article	Year
High-Throughput Screening of Patient-Derived Cultures Reveals Potential for Precision Medicine in Glioblastoma. ACS medicinal chemistry letters, 2015, Aug-13, Volume: 6, Issue:8 Topics:	2015
Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells. Cell death & disease, 2020, 12-11, Volume: 11, Issue:12 Topics: Aniline Compounds; Animals; Apoptosis; Bcl-2-Like Protein 11; Biomarkers, Tumor; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Exosomes; Humans; Mice, Nude; MicroRNAs; Neoplasms; Phenotype; Programmed Cell Death 1 Receptor; Sulfonamides; T-Lymphocytes; Temozolomide	2020

Article

Year

High-Throughput Screening of Patient-Derived Cultures Reveals Potential for Precision Medicine in Glioblastoma.

ACS medicinal chemistry letters, 2015, Aug-13, Volume: 6, Issue:8

Topics:

2015

Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells.

Cell death & disease, 2020, 12-11, Volume: 11, Issue:12

Topics: Aniline Compounds; Animals; Apoptosis; Bcl-2-Like Protein 11; Biomarkers, Tumor; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Exosomes; Humans; Mice, Nude; MicroRNAs; Neoplasms; Phenotype; Programmed Cell Death 1 Receptor; Sulfonamides; T-Lymphocytes; Temozolomide

2020